Prodrugs

A prodrug is a pharmacologically inactive precursor compound that is converted into a biologically active ingredient by the body's own metabolic processes — specifically, by enzymes present in the skin. In cosmetic skincare, prodrugs are engineered to overcome the limitations of traditional actives such as instability, skin irritation, and poor penetration through the skin barrier. Once a prodrug penetrates into the skin's active layers, endogenous enzymes (typically esterases) cleave it to release the pure active compound exactly where it's needed. This approach enables more controlled activation, dramatically improved bioavailability, and consistent clinical results compared to applying the active ingredient directly.

Prodrugs offer several key advantages over conventional actives in cosmetic formulations: (1) Enhanced skin penetration — by chemically modifying an active into a more lipophilic ester form, the prodrug can cross the stratum corneum barrier that blocks the parent active; (2) Improved bioavailability — the active is delivered deeper into the skin layers where it is needed; (3) Greater oxidative stability — prodrug forms are often significantly more stable than their parent actives, simplifying formulation and extending shelf life; (4) Reduced irritation — controlled, enzymatic release of the active prevents the burst-dose exposure that causes irritation with direct application; (5) Targeted delivery — some prodrugs are specifically activated only in target tissues. For example, retinyl acetate (a retinol prodrug) has been shown to have 100% greater skin retention at 24 hours compared to retinol itself.

Actera Ingredients offers three bio-activated cosmetic prodrugs: (1) Adapinoid® (INCI: Oleyl Adapalenate) — the only third-generation retinoid for cosmetic use; a precursor to adapalene that provides powerful anti-aging and anti-acne results with far less irritation than retinol. U.S. Patent No. 12,133,907. (2) TXVector™ (INCI: Cetyl Tranexamate Mesylate) — the first and only form of tranexamic acid that can penetrate to active skin cells, delivering 283% more TXA than conventional tranexamic acid for depigmentation and even skin tone. (3) Trifarotol® (INCI: Trifarotenyl Caprylate) — the only fourth-generation retinoid available for cosmetic use without a prescription; a selective RAR-γ agonist that delivers professional-grade skin renewal with exceptional gentleness.

Adapinoid® (INCI: Oleyl Adapalenate) is a patented third-generation retinoid prodrug (U.S. Patent No. 12,133,907) developed exclusively for cosmetic use by Actera Ingredients. It is a precursor (prodrug) of adapalene, a clinically proven retinoid active. When applied topically, Adapinoid bio-transforms using the skin's own esterase enzymes to slowly release active adapalene into the skin layers. Unlike first-generation retinoids such as retinol and retinoic acid, Adapinoid has significantly fewer toxicity, stability, and skin-irritation concerns. It inhibits inflammatory pathways associated with lipoxygenase (5-LOX and 15-LOX) activity — targeting what is known as inflammaging. Clinical results show Adapinoid delivers 2× greater wrinkle reduction, 10× greater redness reduction, and 70× greater TEWL (transepidermal water loss) reduction compared to retinol. Suggested use level is 0.16–0.5%, added to the oil phase.

TXVector™ (INCI: Cetyl Tranexamate Mesylate) is a cosmetic prodrug of tranexamic acid (TXA) developed by Actera Ingredients. Traditional tranexamic acid is highly hydrophilic with strong hydrogen-bonding capacity, which means it cannot adequately penetrate the skin barrier to reach active keratinocytes and melanocytes. TXVector is an ester form of TXA that possesses superior lipophilicity, allowing it to cross the stratum corneum. Once inside the skin, epidermal esterases cleave TXVector to release the free, active TXA. Comparative in vivo confocal Raman spectroscopy studies confirmed TXVector delivers 283% more active TXA into the skin at various depths compared to equivalent concentrations of conventional TXA. Additionally, TXVector is easier to formulate than other TXA esters, functions as a primary o/w emulsifier, and is water-dispersible. Clinical results: reduced redness in 2 weeks, faded dark spots in 4 weeks, 100% of women observed improved skin uniformity after 8 weeks.

Trifarotol® (INCI: Trifarotenyl Caprylate) is a patented fourth-generation retinoid prodrug — the newest retinoid in the beauty industry and the only one of its class available for cosmetic use without a prescription. It is an ester prodrug of trifarotene, a next-generation retinoid. What makes Trifarotol uniquely differentiated is its receptor selectivity: it bio-transforms via skin enzymes to release active trifarotene, which binds selectively to RAR-γ (retinoic acid receptor gamma) — the receptor located in the outer layers of skin. This targeted binding profile means Trifarotol avoids activating RAR-α and RAR-β, which are associated with the systemic side effects and irritation commonly seen with older retinoids. In a 12-week clinical study, expert-graded results at 8 weeks showed skin smoothness improved by 29.6%, skin clarity by 34.5%, overall skin appearance by 27.1%, and skin tone evenness by 21.8% (all p<0.05), with 100% of consumer participants reporting the product felt gentle on their skin.

Yes. Each of Actera's prodrug ingredients has been clinically evaluated for safety. TXVector™ underwent a Human Repeat Insult Patch Test (HRIPT) with 54 healthy adult volunteers, with no adverse events or sensitization reactions observed. Trifarotol® demonstrated 100% consumer agreement that the formulation felt gentle on skin across a 12-week study. Adapinoid® clinical studies showed dramatically lower redness, TEWL disruption, and irritation compared to retinol. All three ingredients leverage enzymatic activation within the skin, which provides a controlled, gradual release of the active — a mechanism that inherently reduces the irritation potential associated with direct application of potent actives.

Topical prodrugs reduce irritation by preventing "surface toxicity." Traditional high-potency actives often trigger inflammatory responses immediately upon contact with the skin's surface. A prodrug remains chemically "masked" and inactive while sitting on the stratum corneum, only becoming active once it has migrated into the deeper epidermal layers. A prime example is Adapinoid® (Oleyl Adapalenate), which bypasses the typical redness and peeling associated with traditional retinoids.

Retinoid generations reflect the evolution of vitamin A derivatives used in dermatology and cosmetics. First-generation retinoids include retinol, retinaldehyde, and retinoic acid (tretinoin) — effective but often cause significant irritation, photosensitivity, and formulation instability. Second-generation retinoids (etretinate, acitretin) are systemic agents used for severe skin conditions, not typically used in cosmetics. Third-generation retinoids include adapalene — a non-vitamin-A-derived retinoid with improved receptor selectivity and anti-inflammatory properties. Adapinoid® (Oleyl Adapalenate) is the cosmetic prodrug form of adapalene. Fourth-generation retinoids represent the most advanced class, typified by trifarotene, which binds selectively only to RAR-γ. Trifarotol® (Trifarotenyl Caprylate) is the cosmetic prodrug form of trifarotene — the most targeted, gentlest generation of retinoid available for cosmetic use today.

Each of Actera's prodrug ingredients has specific formulation guidance. Adapinoid® should be added to the oil phase at 0.16–0.5% and can be heated up to 85°C to dissolve. TXVector™ is added to the water phase at 1.0–5.0%, heated to 85°C and mixed until clear — it requires a pH of 3.5–5.0, is cationic, and is not compatible with anionic materials; it also functions as a primary o/w emulsifier. Trifarotol® is added to the oil phase at 100 ppm and heated to 80–85°C, and is oxidatively stable with no need for antioxidant additives, special packaging, or controlled fill conditions. Actera provides full technical data sheets, regulatory documents, and sample requests through each ingredient's product page.